Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
LLY
LLY
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
LLY News
ELI LILLY - TALTZ AND ZEPBOUND ACHIEVE PRIMARY AND ALL IMPORTANT SECONDARY ENDPOINTS SHOWING STATISTICAL SUPERIORITY OVER TALTZ MONOTHERAPY AT 36 WEEKS
1d ago
moomoo
Phase 3B Data Revealed at AAD Annual Meeting Demonstrates Enhanced Efficacy of Lilly's Taltz (Ixekizumab) Combined with Zepbound (Tirzepatide) for Adults with Psoriatic Arthritis and Obesity
1d ago
moomoo
ELI LILLY - EBGLYSS MAINTAINS STABLE SAFETY PROFILE WITH NO NEW SAFETY CONCERNS IN ITS FIRST YEAR
2d ago
moomoo
ELI LILLY - EBGLYSS PROVIDES FOUR YEARS OF SUSTAINED DISEASE CONTROL FOR ATOPIC DERMATITIS
2d ago
moomoo
LILLY'S EBGLYSS (LEBRIKIZUMAB-LBKZ) PROVIDES LONG-LASTING DISEASE CONTROL FOR UP TO FOUR YEARS IN PATIENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
2d ago
moomoo
Lilly's EBGLYSS Shows Significant Four-Year Efficacy
2d ago
Yahoo Finance
ELI LILLY SEEKS NHS DRUG PRICE HIKES IN EXCHANGE FOR UK INVESTMENT - FT
5h ago
moomoo
Pfizer Quickly Shifts Strategy After GLP-1 Drug Setback
8h ago
Fool
Pfizer's Rapid Pivot in Response to Challenges
8h ago
NASDAQ.COM
Eli Lilly Signs $2 Billion AI Drug Discovery Deal
8h ago
Yahoo Finance
Pfizer's Strategic Shift in GLP-1 Drug Development
8h ago
Yahoo Finance
InSilico Medicine Partners with Eli Lilly for Drug Discovery
17h ago
NASDAQ.COM
Eli Lilly Partners with Insilico for AI-Developed Drugs
18h ago
Newsfilter
Eli Lilly Strikes $2.75 Billion AI Drug Development Deal with Insilico Medicine
19h ago
seekingalpha
Eli Lilly Partners with Insilico for $2.75 Billion AI Drug Deal
19h ago
CNBC
INSILICO MEDICINE CAYMAN TOPCO TO RECEIVE $115 MILLION INITIAL PAYMENT, WITH POSSIBLE TOTAL DEAL WORTH AROUND $2.75 BILLION
21h ago
moomoo
Show More News
